Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic ...

Diagnosing Alzheimer's disease before people have any symptoms is possible, but brings up concerns when so few treatments are ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

Sex differences in tau may help explain why women face higher Alzheimer's dementia risk than men. At high levels of brain ...

Tau build-up in the brain is associated with Alzheimer’s disease progression. “This unusual pattern might be indicative of ...

In Alzheimer's disease, certain proteins accumulate in brain cells, forming clumps that restrict normal cell function or even ...

2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...